Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
130
Trial Sponsor
Clinical Trial Start Date
2009
0Primary Completion Date
2011
0Study Completion Date
2011
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Intervention Name
Placebo - normal saline0
MGAWN10
Interventional Trial Phase
Phase 20
Official Name
Phase 2, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MGAWN1 in Subjects With Laboratory-documented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus0
Last Updated
February 10, 2022
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Participant0
Outcomes Assessor0
Investigator0
Study summary
This study will test a drug called MGAWN1 for the treatment of West Nile infections.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
